Estratificación del riesgo cardiovascular en pacientes con sobrepeso u obesidad en prevención primaria. Implicaciones en la utilización de estatinas

Endocrinología y Nutrición - Tập 62 - Trang 83-90 - 2015
Walter Masson1, Martín Lobo1, Melina Huerín1, Graciela Molinero1, Diego Manente1, Mario Pángaro1, Laura Vitagliano1, Horacio Zylbersztejn1
1Consejo de Epidemiología y Prevención Cardiovascular, Sociedad Argentina de Cardiología, Buenos Aires, Argentina

Tài liệu tham khảo

Imes, 2014, The obesity epidemic: The United States as a cautionary tale for the rest of the world, Curr Epidemiol Rep., 1, 82, 10.1007/s40471-014-0012-6 Basterra-Gortari, 2007, Tendencias de la obesidad, diabetes mellitus, hipertensión e hipercolesterolemia en España (1997-2003), Med Clin (Barc)., 129, 405, 10.1157/13110464 Bastien, 2014, Overview of epidemiology and contribution of obesity to cardiovascular disease, Prog Cardiovasc Dis, 56, 369, 10.1016/j.pcad.2013.10.016 Whitlock, 2009, Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies, Lancet., 373, 1083, 10.1016/S0140-6736(09)60318-4 Chen, 2013, Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: Pooled analysis of prospective data from the Asia Cohort Consortium, BMJ., 347, f5446, 10.1136/bmj.f5446 Voulgari, 2011, Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals, J Am Coll Cardiol., 58, 1343, 10.1016/j.jacc.2011.04.047 Griera Borrás, 2014, ¿Existe el obeso sano?, Endocrinol Nutr., 61, 47, 10.1016/j.endonu.2013.03.010 Kramer, 2013, Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis, Ann Intern Med., 159, 758, 10.7326/0003-4819-159-11-201312030-00008 Wilson, 1998, Prediction of coronary heart disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837 Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project, Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3 Stone, 2014, ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol., 63, 2889, 10.1016/j.jacc.2013.11.002 Masson, 2014, Estratificación del riesgo cardiovascular utilizando diferentes puntajes de riesgo en prevención primaria. Implicancias en la indicación de estatinas, Rev Arg Cardiol, 10.7775/rac.es.v82.i6.4527 Nambi, 2010, Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study, J Am Coll Cardiol, 55, 1600, 10.1016/j.jacc.2009.11.075 Masson, 2011, Aplicabilidad clínica de la función de Framingham a 30 años. Utilidad en la estratificación del riesgo cardiovascular y en el diagnóstico de placa aterosclerótica carotídea, Rev Esp Cardiol, 64, 305, 10.1016/j.recesp.2010.11.006 Masson, 2013, Estimación del riesgo cardiovascular y detección de ateromatosis carotídea subclínica en mujeres posmenopáusicas de mediana edad, Rev Argent Cardiol, 81, 322, 10.7775/rac.es.v81.i4.1524 2001, Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486 2012, European Heart Journal, 33, 1635, 10.1093/eurheartj/ehs092 Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310 Lau, 2007, 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary], CMAJ, 176, S1, 10.1503/cmaj.061409 Tsigos, 2008, Management of obesity in adults: European clinical practice guidelines, Obesity Facts, 1, 106, 10.1159/000126822 Jensen, 2014, 2013 AHA/ACC/TOS Guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Obesity Society, J Am Coll Cardiol., 63, 2985, 10.1016/j.jacc.2013.11.004 2013 Largent, 2013, Reduction in Framingham risk of cardiovascular disease in obese patients undergoing laparoscopic adjustable gastric banding, Adv Ther., 30, 684, 10.1007/s12325-013-0045-0 Mora, 2005, Interaction of body mass index and framingham risk score in predicting incident coronary disease in families, Circulation., 111, 1871, 10.1161/01.CIR.0000161956.75255.7B Silber, 2008, Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT), Med Klin (Munich)., 103, 638, 10.1007/s00063-008-1103-2 Cristóbal, 2005, Comparison of coronary risk estimates derived using the Framingham and REGICOR equations, Rev Esp Cardiol., 58, 910, 10.1157/13078127 Solomon, 2012, cObesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: A cross-sectional study, Arthritis Res Ther., 14, R67, 10.1186/ar3784 Krämer, 2013, ¿Sirven los marcadores de riesgo no tradicionales en la diferenciación del riesgo cardiovascular en adultos jóvenes con exceso de peso?, Rev Med Chile, 141, 1026, 10.4067/S0034-98872013000800009 Brugts, 2009, The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomised controlled trials, BMJ., 338, b2376, 10.1136/bmj.b2376 Sattar, 2003, Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study, Circulation, 108, 414, 10.1161/01.CIR.0000080897.52664.94 Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med., 359, 2195, 10.1056/NEJMoa0807646